For the Quarter Ending September 2025
North America
• In the United States, the Streptomycin Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by strengthening demand and increased production costs.
• Streptomycin Sulphate production costs increased in Q3 2025 due to an uptick in US natural gas prices and rising industrial electricity costs in September 2025.
• Demand for Streptomycin Sulphate strengthened in Q3 2025, supported by robust retail sales growth of 5.42% in September 2025.
• The Streptomycin Sulphate Price Forecast indicates upward pressure, influenced by persistent inflationary trends with CPI at 3.0% in September 2025.
• The Producer Price Index rose 2.6% in August 2025, reflecting higher input costs for Streptomycin Sulphate manufacturers.
• Strengthening US pharmaceutical market sentiment and surging drug approvals in Q3 2025 bolstered demand, despite 0.1% industrial production growth.
• Agricultural chemicals demand strengthened in Q3 2025 due to pest pressure; unemployment remained stable at 4.3% in September 2025.
• Declining consumer confidence to 94.2 in September 2025 could temper future demand for certain Streptomycin Sulphate applications.
Why did the price of Streptomycin Sulphate change in September 2025 in North America?
• Strengthening US pharmaceutical market sentiment and drug approvals in Q3 2025 boosted demand.
• Production costs increased from natural gas price uptick and rising industrial electricity costs in September 2025.
• Robust retail sales growth of 5.42% in September 2025 supported demand.
APAC
• In China, the Streptomycin Sulphate Price Index fell quarter-over-quarter in Q3 2025, influenced by contracting manufacturing and falling production costs.
• Streptomycin Sulphate production costs decreased in Q3 2025 due to moderated global natural gas prices and corn starch feedstock corrections.
• Demand for pharmaceutical chemicals in China strengthened in Q3 2025, bolstered by growing healthcare needs and an aging population.
• The demand outlook for Streptomycin Sulphate is supported by robust industrial production growth of 6.5% in September 2025.
• Ample corn starch inventories in APAC and significant chemical industry overcapacity in China exerted downward price pressure.
• China's Manufacturing Index contracted in September 2025, while the CPI decreased by 0.3% year-on-year, indicating deflation.
• Retail sales grew 3.0% and the unemployment rate was 5.2% in September 2025, supporting stable consumer spending.
• The Streptomycin Sulphate price forecast suggests continued stability or slight declines due to sustained oversupply and moderated input costs.
Why did the price of Streptomycin Sulphate change in September 2025 in APAC?
• Production costs for Streptomycin Sulphate decreased due to moderated global natural gas prices in Q3 2025.
• Corn starch feedstock costs experienced steeper corrections in Q3 2025, reducing overall manufacturing expenses.
• Ample corn starch inventories and significant chemical overcapacity in China contributed to downward price pressure.
Europe
• In Germany, Streptomycin Sulphate Price Index fell in Q3 2025, due to contracting industrial production and declining input costs.
• Production costs faced upward pressure from elevated energy prices throughout Q3 2025.
• The Producer Price Index declined by 1.7% year-on-year in September 2025, easing manufacturing input costs.
• Demand was supported by firming pharmaceutical output and strengthened agricultural fertilizer demand in Q3 2025.
• Industrial production declined by 1.0% year-on-year in September 2025, aligning with a contracting Manufacturing Index.
• Low consumer confidence (-23.6 index in September 2025) persisted, despite a low 3.9% unemployment rate.
• German chemical production contracted in Q3 2025, with capacity utilization below profitability thresholds.
• Sulfuric Acid feedstock costs declined in September 2025, offering relief to production expenses.
• Retail sales grew by 0.8% year-on-year in September 2025, providing modest indirect support to end-use markets.
Why did the price of Streptomycin Sulphate change in September 2025 in Europe?
• Industrial production declined by 1.0% year-on-year in September 2025, reducing overall demand.
• Producer Price Index declined by 1.7% year-on-year in September 2025, easing manufacturing input costs.
• Elevated energy prices and a 2.4% year-on-year CPI increase in Q3 2025 maintained upward cost pressures.
For the Quarter Ending December 2022
North America
The North American market for Streptomycin Sulphate experienced fluctuating sentiment in the fourth quarter of 2022 due to varying demand from downstream pharmaceutical sectors. Streptomycin Sulphate prices in the US market increased by 7.6% till November and were estimated at USD 36115/MT; however, prices marginally decreased to USD 35445/MT in December.
There were supply chain interruptions from a major exporting country, primarily China, due to the Golden Week holiday in the early week of October and subsequent Covid limitations. Though, the orders from downstream pharmaceutical companies were high due to low stocks, which boosted trader confidence in the domestic market. By the quarter's conclusion, increased import frequency from Chinese ports resulted in sufficient market supply, which caused the cost to be slightly lower. Additionally, a decline in market dynamics resulted from sluggish demand and a subdued consumer mindset before the Christmas holiday.
Asia- Pacific
In the Asia Pacific region, the Streptomycin Sulphate market revealed an assorted sentiment with price fluctuations during the entire fourth quarter of 2022. An increment of 5.3% in Streptomycin Sulphate's price trend was seen in the first half of Q4, with prices settling at USD 33250/MT in November. Low inventories among domestic merchants as a result of the suspension of manufacturing activities over the Golden Week holidays in the first week of October encouraged the upward price trend in the market. Also, the lockdown in Shanghai with rising COVID cases continued to make exports of API unstable. Later, the demand from the downstream pharmacy sector began to decline due to orders being uneven, resulting in a drop in the prices in the second half of Q4. Thus, by the quarter ending December, prices of Streptomycin Sulphate were estimated at USD 32455/MT in China.
Europe
Streptomycin Sulphate had oscillating market dynamics during Europe's fourth quarter of 2022. Streptomycin Sulphate prices in the German market rose to USD 37455/MT till November due to reduced import activity from China over the Golden Week vacation and zero Covid-19 limitations, resulting in low supplies in the local market. Streptomycin Sulphate prices, however, fell 2.4% in December, settling at USD 36560/MT in Germany due to declining demand from the downstream pharmaceutical and nutraceutical sectors, which had impacted the German market's fundamentals and led to a price reduction. Domestic retailers also had adequate inventory to fulfill demand generally, which led to a downward trend towards the end of the quarter.
For the Quarter Ending September 2022
North America
In North America, after Streptomycin Sulphate API CFR Houston prices in the US market settled at $35650/mt in July, debates only dwindled until the middle of the third quarter, when they once more declined and settled at $33520/MT in September. Given that this product is mainly imported as a medicinal ingredient, China's zero-covid policy severely restricted its availability throughout the country. However, domestic retailers had enough stock to satisfy all downstream demand. Due to the heat wave and a power shortage, some Chinese manufacturing facilities were forced to close during the second half of Q3, which had an adverse impact on US commerce and further weakened demand.
Asia Pacific
The domestic Streptomycin Sulphate market trend in the APAC region declined in the third quarter of 2022 as FOB Shanghai prices in China dropped to USD 30050 per MT in August before rising to USD 31560 per MT in September. The low demand in the pharmaceutical industry during the first half of the quarter had a substantial impact on the price chart for this product. However, significant suppliers delayed making large orders because of unforeseen events like the country's severe weather and power disruptions. Later, in the second half, the pharma industry's demand improved. Following the suspension, some manufacturing facilities underwent maintenance when the markets reopened, which also had a detrimental impact.
Europe
In Europe, the third quarter of 2022 began with a rise in the CFR Hamburg price trend for Streptomycin Sulphate API in Germany, whose prices were assembled at $37650 per MT in July and then later declined to USD 34905 per MT in September. The instability in Russia and Ukraine, as well as the lockdown and port restrictions in China, added to the already challenging economic climate in Europe (a major supplier). Additionally, the end-user pharmaceutical industries' offtakes were sluggish in the first half of this quarter which later got worsened in the latter weeks of September.
For the Quarter Ending June 2022
North America
The prices for Streptomycin Sulphate API increased in the second quarter of 2022 with a surge in downstream demand in the North American region. Increased demand from the pharmaceuticals sector amid limited supply in the market resulted in a rise in the price trend. Moreover, disruptions in the market activities of Streptomycin Sulphate API were seen in the second quarter owing to the high logistics and fuel costs amidst a high inflation rate. Prices increased in June due to hampered manufacturing activities and delays in the North American region. Market players passed the rise of input costs to the downstream buyers in the local market during the Q2 of 2022. Towards the end of Q2 of 2022, Streptomycin Sulphate prices were assessed at USD 34290/MT for CFR Houston.
Asia- Pacific
In the Asia Pacific region, the price of Streptomycin Sulphate API showcased an upward trend in Q2 2022 due to firm demand from the pharmaceutical sector. The prices raised in the Indian market due to crippled availability in the domestic market and an unexpected increment in the raw material costs among their production units. Moreover, a surge in the number of cases of Tuberculosis treatment also supported the increment in the demand fundamentals of Streptomycin Sulphate. Meanwhile, excipient prices have risen amidst the two-nations conflicts hampering the supply-demand chain elevated the price momentum of the product during the second quarter of 2022. Thus, Streptomycin Sulphate prices settled at INR 3100604/MT for Ex-Vapi towards the end of Q2 of 2022
Europe
In the European region, the Streptomycin Sulphate API market showcased a bullish sentiment during the second quarter of 2022, with the demand for treatment of Tuberculosis and infection-based products surging in the downstream pharmaceutical sector during this quarter. Moreover, the prices of Streptomycin Sulphate API increased in the second quarter due to a rise in the raw material prices in the regional market. The conflict between Russia and Ukraine throughout the quarter disrupted the overseas supplies for the product. It increased transportation charges amid high crude oil and natural gas prices, consequently causing upward pressure on the costs of the API. Thus, Streptomycin Sulphate prices were evaluated at USD 35880/MT for CFR Hamburg in June 2022
